Koers Sartorius Stedim Biotech
Aandelen
DIM
FR0013154002
Medische apparatuur, benodigdheden & distributie
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
264,3 EUR | +0,76% | -4,27% | +10,35% |
26/03 | Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call | |
12/03 | SARTORIUS STEDIM BIOTECH : Jefferies ontvangt een koopadvies | ZD |
Omzet 2024 * | 3 mld. 3,24 mld. | Omzet 2025 * | 3,44 mld. 3,71 mld. | Marktkapitalisatie | 25,72 mld. 27,77 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 359 mln. 388 mln. | Nettowinst (verlies) 2025 * | 497 mln. 537 mln. | EV/omzet 2024 * | 9,57 x |
Nettoschuld 2024 * | 3,03 mld. 3,28 mld. | Nettoschuld 2025 * | 2,79 mld. 3,01 mld. | EV/omzet 2025 * | 8,28 x |
K/w-verhouding 2024 * |
69,6
x | K/w-verhouding 2025 * |
50,6
x | Werknemers | 10.662 |
Dividendrendement 2024 * |
0,29% | Dividendrendement 2025 * |
0,39% | Vrij verhandelbaar | 31,97% |
Recentste transcriptie over Sartorius Stedim Biotech
1 dag | +0,76% | ||
1 week | -4,27% | ||
Lopende maand | +3,93% | ||
1 maand | +5,34% | ||
3 maanden | +10,26% | ||
6 maanden | +19,70% | ||
Lopend jaar | +10,35% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 26-03-19 |
Chairman | 58 | 29-06-07 | |
Chief Tech/Sci/R&D Officer | 59 | 29-04-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 29-06-07 |
Chairman | 58 | 29-06-07 | |
Susan Dexter
BRD | Director/Board Member | 67 | 07-04-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.42% | 18 M€ | +6,77% | - | |
0.35% | 5 M€ | +4,56% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 264,3 | +0,76% | 48 852 |
27-03-24 | 262,3 | -1,91% | 86 086 |
26-03-24 | 267,4 | -1,40% | 49 596 |
25-03-24 | 271,2 | -3,14% | 54 114 |
22-03-24 | 280 | +1,41% | 37 454 |
Real Time Euronext Paris, 28 maart 2024 om 17:39 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,35% | 27,78 mld. | |
+3,26% | 197 mld. | |
+5,79% | 116 mld. | |
+1,48% | 71,49 mld. | |
+11,77% | 53,47 mld. | |
+18,31% | 48,42 mld. | |
+6,33% | 43,64 mld. | |
+12,38% | 28,97 mld. | |
+9,76% | 28,47 mld. | |
+8,45% | 27,12 mld. |